ArticleEmerging microbes & infections2023

A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern.

I-Jung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.